Meilleure Health International Industry Group Limited reported that its authorised share capital and issued share base were unchanged during May 2026.

Key Points • Authorised share capital stayed at 10.00 billion ordinary shares with a par value of HKD 0.01, representing HKD 100.00 million in nominal terms.

• The issued share count (excluding treasury shares) closed the month at 4.09 billion, while 5.33 million shares continued to be held in treasury. No new shares were issued, cancelled, or transferred.

• Public float remains compliant with Hong Kong’s minimum 25% requirement; management confirmed sufficiency based on publicly available information.

Equity Incentive Programmes • 2019 Share Option Scheme: 16.97 million options outstanding at an exercise price of HKD 0.33, unchanged during the month. The scheme still allows for up to 427.18 million additional shares to be granted.

• 2026 Share Award Scheme: No shares were issued in May, with 408.84 million shares available for future awards.

Share Repurchases Pending Cancellation • A cumulative 33.07 million shares previously repurchased between July 2023 and January 2026 have yet to be cancelled, leaving the total share count unaffected in May.

Overall, Meilleure Health concluded May 2026 with a stable capital structure and maintained regulatory compliance on public float requirements.